Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumonitis caused by mesalazine]

F Pascual Lledó1, J Calvo Bonachera, F Carrasco Miras

  • 1Unidad de Neumología, Hospital La Inmaculada, Huercal-Overa, Almería.

Archivos De Bronconeumologia
|June 1, 1997
PubMed
Summary

Rare lung complications can occur with 5-aminosalicylic acid (5-ASA) treatment for inflammatory bowel disease. This case highlights alveolitis as a potential adverse effect in Crohn

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Acute hepatitis due to ticlopidine. A report of 12 cases and review of the literature].

Revista de neurologia·2002
Same author

[Endobronchial hamartoma: a case report].

Anales de medicina interna (Madrid, Spain : 1984)·2001
Same author

[Pulmonary sarcoidosis with testicular and epididymal disease].

Anales de medicina interna (Madrid, Spain : 1984)·1999
Same author

[Late hydrothorax due to central venous catheterization].

Archivos de bronconeumologia·1999
Same author

[Pulmonary involvement in IgA multiple myeloma. A case report and review of the literature].

Archivos de bronconeumologia·1999
Same author

Norfloxacin-induced cholestatic jaundice.

The American journal of gastroenterology·1998

Area of Science:

  • Pulmonology
  • Gastroenterology

Background:

  • 5-aminosalicylic acid (5-ASA) is a standard treatment for inflammatory bowel diseases like Crohn's disease.
  • While generally safe, rare adverse pulmonary events associated with 5-ASA have been documented.

Observation:

  • A woman with Crohn's disease developed alveolitis during 5-ASA therapy.
  • The case involved specific clinical, biological, and radiological findings.

Findings:

  • The study details a rare instance of 5-ASA-induced lung disease, specifically alveolitis.
  • It outlines the characteristic manifestations and progression of this complication.

Implications:

  • Clinicians should consider 5-ASA-induced lung disease in patients with inflammatory bowel disease presenting with respiratory symptoms.
  • Awareness of this rare side effect is crucial for timely diagnosis and management.

Related Experiment Videos